How MD was paid
$10.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Chandler D. Robinson, MDChief Executive Officer and Director | $700,000 | $550,000 | $6,263,958 | $2,703,862 | $420,000 | — | $10,637,821 |
| Quan VuChief Financial Officer, Secretary, and Treasurer | $305,000 | $100,000 | $746,186 | $795,061 | $137,250 | $17,816 | $2,101,314 |
| Andrew CittadineChief Operating Officer | $440,000 | $325,000 | $2,343,427 | $1,378,004 | $220,000 | — | $4,706,431 |
What changed and why
- $10.6MChief Executive Officer total compensation increased to $10,637,821 due to equity awards and annual bonuses.
- The company shifted compensation timing to award annual incentives in December of the same fiscal year.
- Bonus payouts were driven by clinical data generation, presentations, publications, and capital-raising activities.
- $550KDr. Robinson received a discretionary cash bonus of $550,000 for fiscal year 2025 performance.
- $700KDr. Robinson's base salary was increased to $700,000 during fiscal year 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.